-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, A06Ewc4fMCcbQfoQ6l7eCplanqyGOYLopU1UCZFlTQ3VZq3VoxoQ9z0ba9hCcWEA s9ZCWF45xlGly98Nf0JhJA== 0000732485-03-000031.txt : 20030721 0000732485-03-000031.hdr.sgml : 20030721 20030721113021 ACCESSION NUMBER: 0000732485-03-000031 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030717 FILED AS OF DATE: 20030721 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENZYME CORP CENTRAL INDEX KEY: 0000732485 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 061047163 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQ CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6172527500 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MOSCICKI RICHARD A CENTRAL INDEX KEY: 0001021029 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14680 FILM NUMBER: 03794046 BUSINESS ADDRESS: STREET 1: C/O GENZYME CORP STREET 2: ONE KENDALL SQ CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6172527500 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 mos61.xml X0101 4 2003-07-17 0 0000732485 GENZYME CORP GENZ 0001021029 MOSCICKI RICHARD A 0 1 0 0 Senior Vice President Genzyme General common stock (GENZ) 2003-07-17 2003-07-17 4 M 0 20000 7.27 A 26888 D Genzyme General common stock (GENZ) 2003-07-17 2003-07-17 4 S 0 7000 48.00 D 19888 D Genzyme General common stock (GENZ) 2003-07-17 2003-07-17 4 S 0 5100 48.01 D 14788 D Genzyme General common stock (GENZ) 2003-07-17 2003-07-17 4 S 0 1000 48.03 D 13788 D Genzyme General common stock (GENZ) 2003-07-17 2003-07-17 4 S 0 2500 48.04 D 11288 D Genzyme General common stock (GENZ) 2003-07-17 2003-07-17 4 S 0 300 48.05 D 10988 D Genzyme General common stock (GENZ) 2003-07-17 2003-07-17 4 S 0 500 48.12 D 10488 D Genzyme General common stock (GENZ) 2003-07-17 2003-07-17 4 S 0 208 48.17 D 10280 D Genzyme General common stock (GENZ) 2003-07-17 2003-07-17 4 S 0 300 48.20 D 9980 D Genzyme General common stock (GENZ) 2003-07-17 2003-07-17 4 S 0 100 48.19 D 9880 D Genzyme General common stock (GENZ) 2003-07-17 2003-07-17 4 S 0 100 48.21 D 9780 D Genzyme General common stock (GENZ) 2003-07-17 2003-07-17 4 S 0 1000 48.22 D 8780 D Genzyme General common stock (GENZ) 2003-07-17 2003-07-17 4 S 0 1892 48.23 D 6888 D Genzyme General NQ stock option (right to buy) 43.30 2003-07-10 4 A 0 10000 0 A 2003-07-10 2013-07-10 Genzyme General common stock (GENZ) 10000 10000 D Genzyme General NQ stock option (right to buy) 7.27 2003-07-17 2003-07-17 4 M 0 20000 0 D 2003-06-30 2003-12-08 Genzyme General common stock (GENZ) 20000 60000 D The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 28, 2003. Includes 1,053 shares purchased from the issuer's Employee Stock Purchase Plan on July 9, 2003. The exercise of this stock option included a distribution of an additional 4 shares of Genzyme common stock. These stock options were entitled to receive a distribution of shares of Tissue Repair common stock that was paid on July 22, 1997 to Genzyme General Division stockholders at a rate of 0.015. In connection with the formation of Genzyme Biosurgery in December 2000, shares of Genzyme Tissue Repair were converted into shares of Genzyme Biosurgery at a rate of 0.3352. In connection with the exchange of Genzyme Biosurgery stock into Genzyme General stock on June 30, 2003, distributions of the Genzyme Biosurgery stock are exchanged into Genzyme General stock at a rate of 0.04945. Options vest in 20% annual increments beginning on the original date of grant. By: Susan P. Cogswell, Attorney-in-Fact 2003-07-21 -----END PRIVACY-ENHANCED MESSAGE-----